January 19, 2017
In clinical trials investigating transdermal GLP-1 delivery systems, researchers have explored various wearing durations, including daily and weekly applications
Yes, GLP-1 analogues like semaglutide and tirzepatide can be prescribed for weight management even if you don't have diabetes
Over 72 weeks, participants without type 2 diabetes achieved the following weight loss results : 5 mg dose: 16.0% average body weight reduction 10 mg dose: 21.4% average body weight reduction 15 mg dose: 22.5% average body weight reduction Placebo: 2.4% average body weight reduction At the highest dose, 92.7% of participants achieved at least 5% weight loss, 84.4% achieved at least 10%, 73.6% achieved at least 15%, 56.1% achieved at least 20%, and 38.7% achieved at least 25% weight loss
it's packed with nutrients, fiber, and healthy fats, which keeps me feeling full and satisfied for hours, a major plus for anyone managing their appetite on GLP-1
I had a phone call with one of the physicians, who explained the difference between Zepbound and Wegovy